Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19Case report Published on 2022-09-012022-10-05 Journal: JAAD Case Reports [Category] 치료법, 치료제, [키워드] Casirivimab COVID-19 COVID-19 antiviral drug eruption drug reaction Imdevimab lichenoid lichenoid reaction REGN-CoV2 Treatment [DOI] 10.1016/j.jdcr.2022.07.007 [Article Type] Case report
Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus백만 건 이상의 COVID-19 백신 접종의 실제 증거는 수두 대상포진 바이러스의 재활성화와 일치합니다Article Published on 2022-08-012022-09-11 Journal: Journal of the European Academy of Dermatology and [Category] Coronavirus, MERS, 두창, 수두, 진단, 치료기술, 홍역, [키워드] 95% CI 95% confidence interval accounted Adverse drug reaction adverse event Adverse reaction age and gender assumed calculated cause clinic Cohort COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines database detectable diagnosed drug reaction eruption Evidence Frequency herpes zoster humans Hypothesis incidence individual Infection initial large cohort log-rank test mitigate molecular basis Odds ratio Pathogenesis Patient patients Reactivation real-world data retrieved risk risk ratio shingle shingles significantly higher statistically subject synonym T-cell-mediated immunity vaccination Vaccine Vaccines Varicella-Zoster Virus virus with infections [DOI] 10.1111/jdv.18184 PMC 바로가기 [Article Type] Article
[Treatments for SARS-CoV-2 infection: A retrospective study of drug-drug interactions and safety][SARS-CoV-2 감염 치료: 약물간 상호작용과 안전성에 대한 후향적 연구]Review Published on 2022-07-012022-09-11 Journal: Annales pharmaceutiques françaises [Category] COVID19(2023년), SARS, 치료제, [키워드] Adverse Adverse drug reaction Adverse drug reactions adverse effect adverse effects adverse event adverse events analyzed association Azithromycin Causality caused conducted COVID-19 disease drug drug reaction drug-drug interaction Drug-drug interactions Effets secondaires et réactions indésirables d’origine médicamenteuse English epidemic wave French Hydroxychloroquine Incompatibilité entre médicaments Infection Lopinavir Lopinavir/ritonavir medical record Patient patients patients treated reported Retrospective study risk Ritonavir SARS-CoV-2 SARS-CoV-2 drug SARS-COV-2 infection SARS-CoV-2. [DOI] 10.1016/j.pharma.2021.11.001 PMC 바로가기 [Article Type] Review
Late Onset of ANCA Vasculitis as a Side Effect of Levamisole Treatment in Nephrotic Syndrome신증후군에서 Levamisole 치료의 부작용으로 ANCA 혈관염의 늦은 발병Case Reports Published on 2022-05-112022-09-11 Journal: Medicina [Category] MERS, 바이오마커, 진단, [키워드] Administered affected age alterations ANCA-vasculitis antibody Arthritis autoantibody Awareness Bilirubin Case report celiac disease children circulating clinical manifestation clinical manifestations clinician cocaine cocaine abuse COVID-19 vaccine cumulative cytopenia cytoplasmic decrease demonstrated diagnosed direct bilirubin disease dose drug reaction Effect Fever foot hand high fever induce initial injection joint lack Levamisole liver enzyme liver enzymes manifestation MPO myeloperoxidase nephrotic syndrome nephrotic syndrome. nine Onset positive raise receive reduction in reported returned second dose secondary to side Side effect Side effects steroid Symptom Symptoms syndrome the patient total and direct bilirubin treated Treatment vaccination Vasculitis was measured [DOI] 10.3390/medicina58050650 PMC 바로가기 [Article Type] Case Reports
Does sensitization by SARS-CoV-2 immune complexes trigger DRESS syndrome?SARS-CoV-2 면역 복합체에 의한 감작이 DRESS 증후군을 유발합니까?Case Reports Published on 2022-03-012022-09-12 Journal: The Brazilian journal of infectious diseases : an [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome Affect Autoimmune reaction Comorbidity coronavirus coronavirus disease COVID-19 Diagnosis drug reaction Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome eosinophilia Exanthema immune complex impairment Infection Inflammatory Liver function male organs Patient Respiratory system SARS-CoV-2 SARS-CoV-2. systemic symptom triggered [DOI] 10.1016/j.bjid.2022.102337 PMC 바로가기 [Article Type] Case Reports
Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 VaccinesArticle Published on 2021-09-272022-11-01 Journal: Dermatopathology [Category] COVID-19, [키워드] Adverse Adverse drug reaction adverse event analyzed benefit clinically Coronavirus disease 2019 country COVID-19 COVID-19 vaccine Cutaneous Delayed Department drug reaction eosinophilia female heterogeneous interface dermatitis majority Mild moderate occurred pathophysiological mechanisms Patient reaction required risk Side effect skin biopsies Treatment university vaccination Vaccine with COVID-19 [DOI] 10.3390/dermatopathology8040049 PMC 바로가기 [Article Type] Article
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19Observational Study Published on 2021-08-012022-10-05 Journal: Clinical microbiology and infection : the official [Category] SARS, 임상, [키워드] drug reaction eosinophilia patients with COVID-19 systemic symptom [DOI] 10.1016/j.cmi.2021.05.023 PMC 바로가기 [Article Type] Observational Study
Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era코로나19 시대 약물감시센터 약물안전관리 안내축Article Published on 2021-08-012022-09-11 Journal: International journal of clinical pharmacy [Category] SARS, 치료기술, 치료제, [키워드] Adverse Adverse Drug Event Adverse drug reaction approach Complete COVID-19 COVID-19 pandemic drug drug monitoring drug reaction evaluate fake news Guiding health protection incident Incident Reporting System increase in information knowledge lack management Medicines MONITOR multidimensional pharmacovigilance Pharmacovigilance. processing promote public health Regulatory Authorities Reporting risk Risk management safety profile Scientific community Support the disease therapeutic approaches [DOI] 10.1007/s11096-021-01289-0 PMC 바로가기 [Article Type] Article
Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trialCOVID-19의 장기적인 영향에 대한 아유르베다 중재 및 요가의 안전성 및 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-06-032022-09-10 Journal: Trials [Category] MERS, SARS, 임상, [키워드] 1:1 Acute coronary syndrome acute respiratory distress acute respiratory distress syndrome Adverse Adverse drug reaction Agastya Agastya Haritaki alcoholism ARDS Arm arrhythmia Ashwagandha Atrial fibrillation Ayurveda baseline biochemical blinded Blinding calculated Care CBC change chronic respiratory disease clinical clinical assessment Clinical Management Protocol comparator completion Computed tomography conducted confidence confidence level coronary syndrome COVID 19 COVID-19 COVID-19 case Critically ill Critically ill patient critically ill patients CTRI D-dimer depressive diabetes Diabetes Mellitus diagnosed Diego disease dropout rate drug drug reaction Effect Efficacy element eligible enrolled enrolment evening excluded exploratory study generate GMP Government Government of India group hematological hepatic disease HIV HRCT hs-CRP hypersensitivity IgM antibodies IgM antibody illness illnesses immunosuppressive medications Impact impaired cognition index India intensive care intensive care unit Intervention invasive respiratory support journal Laboratory parameters lactating women Level life long term long-COVID malignancy management motor neuron motor neuron disease multiple sclerosis Myocardial infarction negative RT-PCR number objective Open-label open-label design outcome parallel group parameter participant Participants past history Patient Pharmaceutical Company Pittsburgh positive RT-PCR Post-COVID pregnant Previous studies protocol provided pulmonary Pulmonary function test pulmonary tuberculosis Quality Quality of life random randomised randomised controlled trial Randomized Randomized controlled trial recruitment Registered registry rehabilitation renal renal disease respiratory Respiratory disease respiratory distress Respiratory function Safety Sample Sample size SARS CoV SARS CoV-2 SARS-CoV-2 scale Science score secondary Secondary outcomes Sex Shortness of breath Sleep sleep quality SPSS Standard deviation status stroke study duration study group study period Study protocol Subjective substance dependence supplementary material syndrome Tablet the study group timeline Trial Trial registration Tuberculosis Version warm water water website WHO yoga [DOI] 10.1186/s13063-021-05326-1 PMC 바로가기 [Article Type] Letter
Pleomorphicskin eruptions in a COVID‐19 affected patient: Case report and review of the literatureCOVID-19 환자의 다형성 피부 발진: 증례 보고 및 문헌 검토Review Published on 2021-05-042022-09-10 Journal: Immunity, Inflammation and Disease [Category] 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adverse drug reaction affected Antiviral treatment caused ceftriaxone chronic lymphocytic leukemia Combination Complete Complete Remission coronavirus coronavirus disease Course COVID COVID‐19 cutaneous manifestation Cutaneous manifestations cutaneous reaction darunavir Dermatology diagnose drug reaction enoxaparin erythematous erythematous rash filgrastim Hydroxychloroquine hydroxychloroquine sulfate identify impairment Infection injection leukemia Lymphocytic leukemia occurred Occurrence omeprazole organs Other Viral Diseases oxygen Oxygen therapy Patient Pleomorphic presenting Rash representing respiratory Ritonavir SARS‐CoV‐2 SARS‐CoV‐2 infection severe acute respiratory syndrome Coronavirus skin skin rash sulfate symptomatic symptomatic patient Symptomatic patients the patient treated Treatment undergo urticaria Viral diseases viral exanthem [DOI] 10.1002/iid3.382 PMC 바로가기 [Article Type] Review